» Articles » PMID: 19091864

Inhibition of Lassa and Marburg Virus Production by Tetherin

Overview
Journal J Virol
Date 2008 Dec 19
PMID 19091864
Citations 198
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, tetherin has been identified as an effective cellular factor that prevents the release of human immunodeficiency virus type 1. Here, we show that the production of virus-like particles induced by viral matrix proteins of Lassa virus or Marburg virus was markedly inhibited by tetherin and that N-linked glycosylation of tetherin was dispensable for this antiviral activity. Our data also suggest that viral matrix proteins or one or more components that originate from host cells are targets of tetherin but that viral surface glycoproteins are not. These results suggest that tetherin inhibits the release of a wide variety of enveloped viruses from host cells by a common mechanism.

Citing Articles

Lassa virus protein-protein interactions as mediators of Lassa fever pathogenesis.

Jan S, Phadke K, Lam V, Branda S, Johnson D Virol J. 2025; 22(1):52.

PMID: 40022100 PMC: 11869472. DOI: 10.1186/s12985-025-02669-y.


Role of Type I Interferons during and HIV Infections.

Anes E, Azevedo-Pereira J, Pires D Biomolecules. 2024; 14(7).

PMID: 39062562 PMC: 11275242. DOI: 10.3390/biom14070848.


Interferon-Inducible Guanylate-Binding Protein 5 Inhibits Replication of Multiple Viruses by Binding to the Oligosaccharyltransferase Complex and Inhibiting Glycoprotein Maturation.

Wang S, Li W, Wang L, Tiwari S, Bray W, Wu L bioRxiv. 2024; .

PMID: 38746287 PMC: 11092618. DOI: 10.1101/2024.05.01.591800.


Human BST2 inhibits rabies virus release independently of cysteine-linked dimerization and asparagine-linked glycosylation.

Tanwattana N, Wanasen N, Jantraphakorn Y, Srisutthisamphan K, Chailungkarn T, Boonrungsiman S PLoS One. 2023; 18(11):e0292833.

PMID: 37922253 PMC: 10624315. DOI: 10.1371/journal.pone.0292833.


Host-Pathogen Interactions Influencing Zoonotic Spillover Potential and Transmission in Humans.

Escudero-Perez B, Lalande A, Mathieu C, Lawrence P Viruses. 2023; 15(3).

PMID: 36992308 PMC: 10060007. DOI: 10.3390/v15030599.


References
1.
Vidal-Laliena M, Romero X, March S, Requena V, Petriz J, Engel P . Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry. Cell Immunol. 2005; 236(1-2):6-16. DOI: 10.1016/j.cellimm.2005.08.002. View

2.
Ishikawa J, Kaisho T, Tomizawa H, Lee B, Kobune Y, Inazawa J . Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics. 1995; 26(3):527-34. DOI: 10.1016/0888-7543(95)80171-h. View

3.
Urata S, Noda T, Kawaoka Y, Morikawa S, Yokosawa H, Yasuda J . Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP. J Virol. 2007; 81(9):4895-9. PMC: 1900181. DOI: 10.1128/JVI.02829-06. View

4.
Neil S, Zang T, Bieniasz P . Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 2008; 451(7177):425-30. DOI: 10.1038/nature06553. View

5.
Goto T, Kennel S, Abe M, Takishita M, Kosaka M, Solomon A . A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood. 1994; 84(6):1922-30. View